Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [215]
News [411]
Articles [75]
Editorials [2]
Conferences [66]
elearning [9]
ECC 2013: First randomised trial of targeted cancer medicine in all tumour types
ECC 2013: First randomised trial of targeted cancer medicine in all tumour types
Discount for ecancer members at the 2013 WIN Symposium
Discount for ecancer members at the 2013 WIN Symposium
Half of UK will get cancer in their lifetime by 2020
Half of UK will get cancer in their lifetime by 2020
Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas
Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas
Latin America risks being “overwhelmed” by burgeoning cancer epidemic
Latin America risks being “overwhelmed” by burgeoning cancer epidemic
Medical Education Workshop on Molecular Targeted Therapy of Cancer
Medical Education Workshop on Molecular Targeted Therapy of Cancer
New drug overcomes resistance in patients with rare sarcoma
New drug overcomes resistance in patients with rare sarcoma
New marker, new target in Ewing's sarcoma
New marker, new target in Ewing's sarcoma
Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma
Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma
Common signs of cancer missed in a third of UK young people
Common signs of cancer missed in a third of UK young people

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation